Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 7.115 USD -5.13%
Market Cap: 402.9m USD
Have any thoughts about
Design Therapeutics Inc?
Write Note

Income Statement

Earnings Waterfall
Design Therapeutics Inc

Revenue
0 USD
Operating Expenses
-60.8m USD
Operating Income
-60.8m USD
Other Expenses
13m USD
Net Income
-47.8m USD

Income Statement
Design Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(13)
(25)
(36)
(44)
(51)
(59)
(68)
(76)
(83)
(82)
(78)
(71)
(63)
(61)
Selling, General & Administrative
(4)
(7)
(11)
(14)
(16)
(18)
(19)
(20)
(21)
(22)
(21)
(20)
(19)
(18)
Research & Development
(9)
(17)
(25)
(30)
(36)
(42)
(49)
(56)
(61)
(60)
(57)
(51)
(45)
(43)
Operating Income
(13)
N/A
(25)
-85%
(36)
-45%
(44)
-21%
(51)
-18%
(59)
-15%
(68)
-14%
(76)
-12%
(83)
-9%
(82)
+0%
(78)
+5%
(71)
+9%
(63)
+11%
(61)
+4%
Pre-Tax Income
Total Other Income
0
0
0
0
1
2
4
7
9
10
11
12
13
13
Pre-Tax Income
(13)
N/A
(24)
-86%
(36)
-45%
(43)
-22%
(51)
-17%
(57)
-13%
(63)
-11%
(69)
-10%
(74)
-7%
(72)
+3%
(67)
+8%
(59)
+12%
(51)
+14%
(48)
+5%
Net Income
Income from Continuing Operations
(13)
(24)
(36)
(43)
(51)
(57)
(63)
(69)
(74)
(72)
(67)
(59)
(51)
(48)
Net Income (Common)
(13)
N/A
(24)
-86%
(36)
-45%
(43)
-22%
(51)
-17%
(57)
-13%
(63)
-11%
(69)
-10%
(74)
-7%
(72)
+3%
(67)
+8%
(59)
+12%
(51)
+14%
(48)
+5%
EPS (Diluted)
-0.23
N/A
-0.44
-91%
-0.77
-75%
-0.79
-3%
-0.92
-16%
-1.03
-12%
-1.14
-11%
-1.25
-10%
-1.34
-7%
-1.3
+3%
-1.19
+8%
-1.05
+12%
-0.9
+14%
-0.85
+6%

See Also

Discover More